Balance Sheet - Lyell Immunopharma, Inc. (LYEL)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 0.25 | 0.37 | 0.55 | 0.64 | 0.61 | 0.61 | 0.44 |
| Other current assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Total current assets | 0.26 | 0.38 | 0.55 | 0.65 | 0.63 | 0.62 | 0.44 |
| Total non-current assets | 0.08 | 0.11 | 0.20 | 0.29 | 0.50 | 0.29 | 0.12 |
| Total assets | 0.34 | 0.49 | 0.75 | 0.94 | 1.13 | 0.91 | 0.56 |
| Total current liabilities | 0.05 | 0.05 | 0.03 | 0.04 | 0.05 | 0.05 | 0.02 |
| Total non-current liabilities | 0.04 | 0.05 | 0.06 | 0.07 | 0.15 | 0.14 | 0.13 |
| Total liabilities | 0.09 | 0.11 | 0.10 | 0.10 | 0.20 | 0.19 | 0.15 |
| Total stockholders' equity | 0.25 | 0.38 | 0.65 | 0.83 | 0.93 | 0.72 | 0.41 |
| Common shares outstanding | 17 | 13 | 13 | 12 | 12 | 12 | 12 |
Show Quarterly Balance Sheet
Balance Sheet - Lyell Immunopharma, Inc. (LYEL)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 0.25 | 0.25 | 0.32 | 0.28 | 0.30 | 0.37 | 0.44 | 0.49 | 0.53 | 0.55 | 0.58 | 0.60 | 0.61 | 0.64 | 0.65 | 0.66 | 0.61 | 0.61 | 0.62 | 0.82 | 0.60 | 0.61 | 0.00 | 0.00 | 0.44 |
| Other current assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | |||
| Total current assets | 0.27 | 0.26 | 0.33 | 0.28 | 0.31 | 0.38 | 0.45 | 0.50 | 0.53 | 0.55 | 0.59 | 0.61 | 0.62 | 0.65 | 0.66 | 0.67 | 0.63 | 0.63 | 0.63 | 0.83 | 0.61 | 0.62 | 0.44 | ||
| Total non-current assets | 0.08 | 0.08 | 0.08 | 0.10 | 0.12 | 0.11 | 0.17 | 0.15 | 0.16 | 0.20 | 0.21 | 0.23 | 0.26 | 0.29 | 0.32 | 0.35 | 0.45 | 0.50 | 0.57 | 0.40 | 0.27 | 0.29 | -0.44 | ||
| Total assets | 0.35 | 0.34 | 0.41 | 0.39 | 0.43 | 0.49 | 0.62 | 0.65 | 0.69 | 0.75 | 0.79 | 0.84 | 0.88 | 0.94 | 0.98 | 1.02 | 1.07 | 1.13 | 1.20 | 1.23 | 0.88 | 0.91 | |||
| Total current liabilities | 0.04 | 0.05 | 0.03 | 0.04 | 0.04 | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | 0.04 | 0.05 | 0.05 | 0.04 | 0.05 | 0.06 | 0.06 | 0.06 | 0.05 | |||
| Total non-current liabilities | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 | 0.07 | 0.11 | 0.10 | 0.15 | 0.15 | 0.15 | 0.14 | 0.14 | 0.14 | |||
| Total liabilities | 0.08 | 0.09 | 0.08 | 0.09 | 0.09 | 0.11 | 0.09 | 0.09 | 0.09 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.16 | 0.15 | 0.19 | 0.20 | 0.21 | 0.21 | 0.20 | 0.19 | |||
| Total stockholders' equity | 0.27 | 0.25 | 0.33 | 0.30 | 0.34 | 0.38 | 0.53 | 0.57 | 0.60 | 0.65 | 0.70 | 0.74 | 0.78 | 0.83 | 0.82 | 0.87 | 0.88 | 0.93 | 0.99 | 1.02 | 0.68 | 0.72 | 0.41 | ||
| Common shares outstanding | 22 | 17 | 18 | 15 | 15 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |